MENU
ALIM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Alimera Sciences (ALIM) Ownership - Who owns Alimera Sciences?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
6310 Town Square
Phone
+1 678 990-5740
Employees
159
Web
https://www.alimerasciences.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
204.18M
P/E Ratio
15.80
Total Cash
12.06M
Projected Growth
N/A
Total Debt
65.32M
Revenue
80.75M
Risk (Beta)
0.74
Dividend Yield
N/A
Total Cash/Share
0.23
Total Debt/Equity
41.83
Revenue/Share
3.16 USD as % of share price
Fundamentals
ALIM
Capitalization
204M
P/E Ratio
15.80
Risk (Beta)
0.74
Dividend Yield
N/A
Total Cash
12.1M
Total Cash/Share
0.23
Total Debt
65.3M
Total Debt/Equity
41.83
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.16%
Revenue
80.8M
ROE
N/A
Book Value
46.2M
P/B Ratio
4.36
Cash Flow
N/A
Earnings
-0.84
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
524K
Current Ratio
2.39
Current Revenue Per Employee
166493.67
Dividends Per Share - Security
N/A
EBITDA
-1.12M
Float
N/A
Float - Current
N/A
Gross Income Margin
86.22
Revenue To Assets
-21.81
Shares Held By Institutions
214M
Shares Outstanding - Current
52.4M
Total Liabilities
107M
Total Volume MTD
N/A
Value
-1
Gain YTD
27.778
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of ophthalmic pharmaceuticals
Industry PharmaceuticalsOther
Profile
Fundamentals
Details
Industry
Biotechnology
Address
6310 Town Square
Phone
+1 678 990-5740
Employees
159
Web
https://www.alimerasciences.com